Clinical Trial

Prospective Gastric Cancer Screening Using Helicobacter Pylori High-Risk Single Nucleotide Polymorphism Detection

Recruiting
View on ClinicalTrials.gov →
Summary
This is a prospective study designed to compare the performance of fecal H. pylori gastric cancer susceptibility analysis and the gastric cancer risk questionnaire for the early detection of gastric cancer. The primary objective is to assess whether each method, individually or in combination, can facilitate earlier diagnosis of gastric cancer. All participants will undergo fecal H. pylori gastric cancer susceptibility testing and complete the gastric cancer risk questionnaire.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-04-22; most recent amendment 2026-02-23.
Status change: Not Yet Recruiting → Recruiting 2026-02-23
Trial Details
NCT Number NCT06943781
Lead Sponsor Fudan University
Conditions Gastric Adenocarcinoma, Helicobacter Pylori
Enrollment 15,000 participants
Start Date 2025-07-01
Primary Completion 2027-07-01 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-25